Answers are grounded in this paper and cite their sources.
Guidelines recommend strategies for preventing and managing adverse events in patients receiving dinutuximab beta, indicating their overall safety.
The guidelines for the prevention and management of adverse events in patients receiving dinutuximab beta therapy provide recommendations for assessing the risk of development, prevention and management of adverse events.
No takes yet. Share an insight, caveat, or question.
Sagoyan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: